18 related articles for article (PubMed ID: 38489486)
1. A novel subtype based on driver methylation-transcription in lung adenocarcinoma.
Wang X; Xu Z; Zhao S; Song J; Yu Y; Yang H; Hou Y
J Cancer Res Clin Oncol; 2024 May; 150(5):269. PubMed ID: 38777866
[TBL] [Abstract][Full Text] [Related]
2. Wemics: A Single-Base Resolution Methylation Quantification Method for Enhanced Prediction of Epigenetic Regulation.
Liu Y; Yi J; Wu P; Zhang J; Li X; Li J; Zhou L; Liu Y; Xu H; Chen E; Zhang H; Liang M; Liu P; Pan X; Lu Y
Adv Sci (Weinh); 2024 Jun; 11(21):e2308884. PubMed ID: 38544480
[TBL] [Abstract][Full Text] [Related]
3. Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression.
Jilani M; Degras D; Haspel N
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790260
[TBL] [Abstract][Full Text] [Related]
4. Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways.
Gatenby RA; Luddy KA; Teer JK; Berglund A; Freischel AR; Carr RM; Lam AE; Pienta KJ; Amend SR; Austin RH; Hammarlund EU; Cleveland JL; Tsai KY; Brown JS
Med Oncol; 2024 May; 41(6):135. PubMed ID: 38704802
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis.
Pan X; Ji P; Deng X; Chen L; Wang W; Li Z
Gene; 2022 Feb; 810():146054. PubMed ID: 34737001
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer.
Ankill J; Aure MR; Bjørklund S; Langberg S; ; Kristensen VN; Vitelli V; Tekpli X; Fleischer T
NAR Cancer; 2022 Mar; 4(1):zcac008. PubMed ID: 35350772
[TBL] [Abstract][Full Text] [Related]
7. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
8. EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma.
Xu Z; Qin F; Yuan L; Wei J; Sun Y; Qin J; Deng K; Zheng T; Li S
Front Oncol; 2021; 11():691915. PubMed ID: 34447695
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Su Y; Shetty A; Jiang F
Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.
Brativnyk A; Ankill J; Helland Å; Fleischer T
Int J Cancer; 2024 Jul; 155(2):282-297. PubMed ID: 38489486
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
